About 3Brain
3Brain is a company based in Wadenswil (Switzerland) founded in 2011. 3Brain offers products and services including HyperCAM Alpha, BioCAM DupleX, BrainWave 5, and CorePlate Multi-well. 3Brain operates in a competitive market with competitors including Metabolon, Maze Therapeutics, Seer, Alector and Scailyte, among others.
- Headquarter Wadenswil, Switzerland
- SectorsHealthcare
- Email••••••••
- Website 3brain.com
- Social LinkedIn X YouTube
- Legal Name 3Brain Ag
- Latest Funding Round$649.07K (USD), Grant
Sep 2021
- Investors
Products & Services of 3Brain
3Brain offers a comprehensive portfolio of products and services, including HyperCAM Alpha, BioCAM DupleX, BrainWave 5, and CorePlate Multi-well.
Multi-well system for high-resolution functional screening in neuroscience.
Bi-directional system for 2D and 3D in vitro electrophysiology analysis.
Tool for recording and analyzing biosignals in real-time.
Plates with CMOS chips for biological signal optimization.
Apps and channels of 3Brain
its YouTube channel 3Brain has 190 subscribers and 30 videos.
Videos from 3Brain
The most watched videos on 3Brain's YouTube channel, 3Brain (190 subscribers). Click a video to play it here.
More on 3Brain.
Funding Insights of 3Brain
- Total Rounds 2
- Last Round Grant — $649,068
- First Round $649,068
(Jan 2021)
- Investors Count 1
All 2 funding rounds of 3Brain with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2021 | $649,068 | Grant | – | – | |
| Jan 2021 | $649,068 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in 3Brain
3Brain has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for 3Brain
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of 3Brain
8 people are tracked at 3Brain (4 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Mauro Gandolfo | CEO | Leadership |
Kilian Imfeld | Ph.d., CTO | Leadership |
Aleksandar Godjoski | Head Of Data Analysis | Leadership |
Marco Aquila | Ph.d., Vice President, Global Sales | Leadership |
Sercan Deniz | Senior Sales Manager | Team |
Alessandro Maccione | Ph.d., CSO | Team |
Gonzalo Salvador Oyarzabal | Embedded Software Engineer | Team |
Elisa Monz | Senior Sales Manager | Team |
Complete people profiles for 3Brain
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of 3Brain
3 dated milestones of 3Brain across 10 years, from founding to its latest funding, stage changes and deals.
- Founded 3Brain is founded.
- Funding First funding round of $649K.
- Funding Latest funding round, Grant, of $649K.
Competitors of 3Brain
3Brain operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Maze Therapeutics, Seer, Alector and Scailyte, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| metabolon.com | 2000 | Morrisville, United States | $165.87M | 189 | Solutions for biomarker discovery and diagnostic testing are provided. | |
| mazetx.com | 2018 | Redwood, United States | $496M | 111 | Genetic biomarkers are developed for neurological, metabolic, and renal diseases. | |
| seer.bio | 2017 | San Francisco, United States | $127.5M | 89 | Proteomics platform developed for early cancer and neurological disease detection. | |
| alector.com | 2013 | San Francisco, United States | $214.78M | 211 | Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | |
| scailyte.com | 2017 | Lucerne, Switzerland | $20.26M | – | Single-cell data is analyzed via AI for biomarker discovery. | |
| neophore.com | 2017 | Cambridge, United Kingdom | $44.56M | 10 | NeoPhore is focused on cancer neoantigen evolution therapies. | |
| tangotx.com | 2017 | Cambridge, United States | $165M | 140 | Novel cancer drugs are developed using synthetic lethality screening. | |
| singulex.com | 1997 | Alameda, United States | $140.94M | 236 | Single-molecule counting technology is developed for cardiovascular biomarker detection. | |
| denovobiopharma.com | 2013 | San Diego, United States | $171.82M | 42 | Genomic biomarker discovery platform is developed for drug personalization. | |
| lexpharma.com | 1995 | United States | $165M | 135 | Small molecule drugs for various therapeutic areas are developed. |
Detailed competitors of 3Brain
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of 3Brain
The website of 3Brain (3brain.com) receives about 9.7K visits a month.
- Monthly visits9.7K
▼ 16.2% vs previous month
Websites whose visitors overlap most with 3Brain. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mxwbio.com | 100% | 22.5K | #1,121,454 | View details | |
| multichannelsystems.com | 94% | 123.5K | #370,590 | View details | |
| axionbiosystems.com | 83% | 35.5K | #817,660 | View details | |
| xing.com | 31% | 10.3M | #5,170 | View details |
Similar companies to 3Brain
10 companies that operate in the same segment as 3Brain (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about 3Brain
3Brain was founded in 2011 and raised its 1st funding round 10 years after it was founded.
3Brain is headquartered in Wadenswil, Switzerland. It is registered at Wadenswil, Zurich, Switzerland.
3Brain was founded in 2011 in Wadenswil, Switzerland, within the biotech sector focused on in-vitro electrophysiology. Large-scale high-resolution microelectrode array recording platforms and CMOS-MEA biochips are developed and sold. Core operations center on CMOS integrated bio-sensor arrays that record extracellular signals from electrogenic cells, neuronal networks, brain slices, and cardiac tissues. Support is provided by institutions including CSEM and the Fondazione Istituto Italiano di Tecnologia.
3Brain's top competitors include Alector, Lexicon Pharmaceuticals and Maze Therapeutics.
3Brain offers HyperCAM Alpha, BioCAM DupleX, BrainWave 5, and CorePlate Multi-well.
3Brain has 1 investor. Key investors include European Union.
3Brain operates through 3Brain Ag.